{"id":"https://openalex.org/W2001763447","doi":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","title":"Cost-Effectiveness of Dexamphetamine and Methylphenidate for the Treatment of Childhood Attention Deficit Hyperactivity Disorder","display_name":"Cost-Effectiveness of Dexamphetamine and Methylphenidate for the Treatment of Childhood Attention Deficit Hyperactivity Disorder","alternate_titles":[],"publication_year":2004,"publication_date":"2004-08-01","ids":{"openalex":"https://openalex.org/W2001763447","doi":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","mag":"2001763447","pmid":"https://pubmed.ncbi.nlm.nih.gov/15298581"},"language":"en","primary_location":{"id":"doi:10.1080/j.1440-1614.2004.01422.x","doi":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","is_oa":false,"landing_page_url":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","pdf_url":null,"source":{"id":"https://openalex.org/S179943861","display_name":"Australian & New Zealand Journal of Psychiatry","issn_l":"0004-8674","issn":["0004-8674","1440-1614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian &amp; New Zealand Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2001763447"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017191873","display_name":"Marie Donnelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie Donnelly","raw_affiliation_strings":["Monash University, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash University, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085033637","display_name":"Michelle M. Haby","orcid":"https://orcid.org/0000-0001-6203-9195","observed_orcids":["https://orcid.org/0000-0001-6203-9195"]},"institutions":[{"id":"https://openalex.org/I4210091014","display_name":"Department of Health and Human Services","ror":"https://ror.org/00b9jhh55","country_code":"AU","type":"government","lineage":["https://openalex.org/I2801037857","https://openalex.org/I4210091014"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michelle M. Haby","raw_affiliation_strings":["Department of Human Services, Health Surveillance and Evaluation Section, Public Health, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Services, Health Surveillance and Evaluation Section, Public Health, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I4210091014"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069227552","display_name":"Rob Carter","orcid":"https://orcid.org/0000-0002-1586-5619","observed_orcids":["https://orcid.org/0000-0002-1586-5619"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Carter","raw_affiliation_strings":["Program Evaluation Unit, University of Melbourne, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Evaluation Unit, University of Melbourne, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I165779595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026420405","display_name":"Gavin Andrews","orcid":"https://orcid.org/0000-0002-4315-2173","observed_orcids":["https://orcid.org/0000-0002-4315-2173"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gavin Andrews","raw_affiliation_strings":["CRUfAD, University of New South Wales, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRUfAD, University of New South Wales, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007119101","display_name":"Theo Vos","orcid":"https://orcid.org/0000-0002-5690-5365","observed_orcids":["https://orcid.org/0000-0002-5690-5365"]},"institutions":[{"id":"https://openalex.org/I4210091014","display_name":"Department of Health and Human Services","ror":"https://ror.org/00b9jhh55","country_code":"AU","type":"government","lineage":["https://openalex.org/I2801037857","https://openalex.org/I4210091014"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theo Vos","raw_affiliation_strings":["Department of Human Services, Health Surveillance and Evaluation Section, Public Health, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Services, Health Surveillance and Evaluation Section, Public Health, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I4210091014"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.3569,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.32673267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"38","issue":"8","first_page":"592","last_page":"601"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0421999990940094,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9179999828338623},{"id":"https://openalex.org/keywords/childhood-adhd","display_name":"childhood ADHD","score":0.828000009059906},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":1.0},{"id":"https://openalex.org/keywords/stimulant-medication","display_name":"stimulant medication","score":0.8849999904632568},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9940000176429749},{"id":"https://openalex.org/keywords/disability-adjusted-life-years","display_name":"disability-adjusted life years","score":0.6930000185966492},{"id":"https://openalex.org/keywords/pharmaceutical-benefits-scheme","display_name":"Pharmaceutical Benefits Scheme","score":0.703000009059906},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.5299999713897705},{"id":"https://openalex.org/keywords/resource-allocation","display_name":"resource allocation","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.9037615060806274},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.718082845211029},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.6723322868347168},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.6041309237480164},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5138771533966064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5075875520706177},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5004079341888428},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.4885424077510834},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4358384609222412},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3312247395515442},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008605","descriptor_name":"Mental Health Services","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/j.1440-1614.2004.01422.x","doi":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","is_oa":false,"landing_page_url":"https://doi.org/10.1080/j.1440-1614.2004.01422.x","pdf_url":null,"source":{"id":"https://openalex.org/S179943861","display_name":"Australian & New Zealand Journal of Psychiatry","issn_l":"0004-8674","issn":["0004-8674","1440-1614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian &amp; New Zealand Journal of Psychiatry","raw_type":"journal-article"},{"id":"doi:10.1111/j.1440-1614.2004.01422.x","doi":"https://doi.org/10.1111/j.1440-1614.2004.01422.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1614.2004.01422.x","pdf_url":null,"source":{"id":"https://openalex.org/S179943861","display_name":"Australian & New Zealand Journal of Psychiatry","issn_l":"0004-8674","issn":["0004-8674","1440-1614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian and New Zealand Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:15298581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15298581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Australian and New Zealand journal of psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315885","display_name":"Australian Government","ror":"https://ror.org/0314h5y94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W21645691","https://openalex.org/W35345420","https://openalex.org/W86177894","https://openalex.org/W186268426","https://openalex.org/W1520169070","https://openalex.org/W1521375496","https://openalex.org/W1595184853","https://openalex.org/W1962704273","https://openalex.org/W1971744303","https://openalex.org/W1976980182","https://openalex.org/W1978481128","https://openalex.org/W1986786081","https://openalex.org/W1998328668","https://openalex.org/W1998438805","https://openalex.org/W2004968413","https://openalex.org/W2018129806","https://openalex.org/W2020837599","https://openalex.org/W2022113252","https://openalex.org/W2024097447","https://openalex.org/W2024285816","https://openalex.org/W2027445358","https://openalex.org/W2027974893","https://openalex.org/W2045411458","https://openalex.org/W2048036531","https://openalex.org/W2054522605","https://openalex.org/W2054555385","https://openalex.org/W2061256954","https://openalex.org/W2063286745","https://openalex.org/W2073199272","https://openalex.org/W2080321082","https://openalex.org/W2091804977","https://openalex.org/W2093147795","https://openalex.org/W2102051925","https://openalex.org/W2103032613","https://openalex.org/W2124174561","https://openalex.org/W2130235475","https://openalex.org/W2131342243","https://openalex.org/W2158377281","https://openalex.org/W2285134444","https://openalex.org/W2327735791","https://openalex.org/W2413599611","https://openalex.org/W2462690550","https://openalex.org/W2601578636","https://openalex.org/W2890695184","https://openalex.org/W3139845868","https://openalex.org/W3153732840","https://openalex.org/W4210688458","https://openalex.org/W4231356977","https://openalex.org/W4240143700","https://openalex.org/W4249508602","https://openalex.org/W4249794041","https://openalex.org/W4252093710"],"related_works":["https://openalex.org/W2594901718","https://openalex.org/W2165990772","https://openalex.org/W4387495021","https://openalex.org/W7222806850","https://openalex.org/W2383918203","https://openalex.org/W2176379477","https://openalex.org/W352619735","https://openalex.org/W2102544290","https://openalex.org/W2063410187","https://openalex.org/W2076180621"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1,63],"analyze":[2],"from":[3],"a":[4,67,124,208],"health":[5,65],"sector":[6],"perspective":[7],"the":[8,33,80,130,177,184,212,232,245],"cost-effectiveness":[9,132],"of":[10,69,97,223,234,239],"dexamphetamine":[11],"(DEX)":[12],"and":[13,40,48,77,79,100,159,188,236,244],"methylphenidate":[14],"(MPH)":[15],"interventions":[16,34,192],"to":[17,26,102,107,122,156],"treat":[18],"childhood":[19,194],"attention":[20],"deficit":[21],"hyperactivity":[22],"disorder":[23],"(ADHD),":[24],"compared":[25],"current":[27],"practice.":[28],"METHOD:":[29],"Children":[30],"eligible":[31],"for":[32,52,75,148,160,176,183,193,225],"are":[35,120,190],"those":[36],"aged":[37],"between":[38],"4":[39],"17":[41],"years":[42],"in":[43,138],"2000,":[44],"who":[45],"had":[46],"ADHD":[47,226],"were":[49,58,83,205],"seeking":[50],"care":[51],"emotional":[53],"or":[54],"behavioural":[55],"problems,":[56],"but":[57,179],"not":[59],"receiving":[60],"stimulant":[61],"medication.":[62],"determine":[64],"benefit,":[66],"meta-analysis":[68],"randomized":[70],"controlled":[71],"trials":[72],"was":[73],"performed":[74],"DEX":[76,149,170,189,196],"MPH,":[78,201],"effect":[81],"sizes":[82],"translated":[84],"into":[85],"utility":[86],"values.":[87],"An":[88],"assessment":[89],"on":[90,113,211],"second":[91],"stage":[92],"filter":[93],"criteria":[94],"(\"equity\",":[95],"\"strength":[96],"evidence\",":[98],"\"feasibility\"":[99],"\"acceptability":[101],"stakeholders\")":[103],"is":[104,136,150,162,171,197],"also":[105],"undertaken":[106],"incorporate":[108],"additional":[109],"factors":[110],"that":[111],"impact":[112],"resource":[114],"allocation":[115],"decisions.":[116],"Simulation":[117],"modelling":[118],"techniques":[119],"used":[121],"present":[123],"95%":[125],"uncertainty":[126],"interval":[127],"(UI)":[128],"around":[129],"incremental":[131],"ratio":[133],"(ICER),":[134],"which":[135],"calculated":[137],"cost":[139],"(in":[140],"A$)":[141],"per":[142],"DALY":[143],"averted.":[144],"RESULTS:":[145],"The":[146],"ICER":[147],"A$4100/DALY":[151],"saved":[152,165],"(95%":[153,166],"UI:":[154,167],"negative":[155],"A$14":[157],"000)":[158],"MPH":[161,175,187,204],"A$15":[163],"000/DALY":[164],"A$9100-22":[168],"000).":[169],"more":[172,198,219],"costly":[173,182],"than":[174,200],"government,":[178],"much":[180],"less":[181],"patient.":[185],"CONCLUSIONS:":[186],"cost-effective":[191,199],"ADHD.":[195],"although":[202],"if":[203],"listed":[206],"at":[207],"lower":[209],"price":[210],"Pharmaceutical":[213],"Benefits":[214],"Scheme":[215],"it":[216],"would":[217,227],"become":[218],"cost-effective.":[220],"Increased":[221],"uptake":[222],"stimulants":[224,240],"require":[228],"policy":[229],"change.":[230],"However,":[231],"medication":[233],"children":[235],"wider":[237],"availability":[238],"may":[241],"concern":[242],"parents":[243],"community.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2001763447","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
